AVID BIOSCIENCES
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for the treatment and diagnosis of cancer. The Company has two platforms and are pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab, its PS-targeting agent, 124I-PGN650 (PGN650), and its brain cancer therapy Cotara. Bavituximab is the Company’s therapeutic PS-targeting antibody. PGN650 is its PS-targeting imaging agent. The Com... pany has conducted three randomized Phase II trials for bavituximab in combination with standard chemotherapy in both front and second-line NSCLC as well as front-line pancreatic cancer. In addition, it has four ongoing ISTs evaluating bavituximab with additional drug combinations in additional oncology indications
AVID BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
1981-01-01
Address:
Tustin, California, United States
Country:
United States
Website Url:
http://www.avidbio.com
Total Employee:
251+
Status:
Active
Contact:
7148389433
Total Funding:
285 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon Virginia Region Vimeo Akamai Hosted Level 3 Communications
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
2021-07-01
Board_member
2017-10-01
Current Employees Featured
Mark Ziebell General Counsel, Corporate Secretary @ Avid Biosciences
General Counsel, Corporate Secretary
2012-06-01
Matthew Kwietniak Chief Commercial Officer (CCO) @ Avid Biosciences
Chief Commercial Officer (CCO)
2021-10-01
Oksana Lukash VP, People @ Avid Biosciences
VP, People
2022-10-01
Jeff Hutchins Vice President, Preclinical Research @ Avid Biosciences
Vice President, Preclinical Research
2012-09-01
Pramthesh Patel Vice President, Process Development for Mammalian Cell Business @ Avid Biosciences
Vice President, Process Development for Mammalian Cell Business
2022-01-01
Founder
Stock Details
Newest Events participated
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Participated in BioProcess International West 2017
on 2017-02-27 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.avidbio.com Semrush global rank: 938.43 K Semrush visits lastest month: 29.72 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avid Biosciences"
Avid Bioservices to be Acquired by GHO Capital Partners and …
The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com …See details»
Avid Bioservices
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept all," you consent to our use of cookies.See details»
GHO & Ampersand Complete Acquisition of Avid Bioservices
Feb 5, 2025 Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing …See details»
Avid Bioservices Launches New Company Website Designed to …
Feb 10, 2025 Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of …See details»
Avid Bioservices - EverybodyWiki Bios & Wiki
Avid Bioservices (known as Peregrine Pharmaceuticals, Inc. until January 2018) [1] is a publicly-traded American contract manufacturing organization; it was formerly a biopharmaceutical …See details»
GHO Capital and Ampersand Complete Acquisition of Avid
Feb 5, 2025 GHO Capital Partners and Ampersand Capital Partners have successfully completed the acquisition of Avid Bioservices, a biologics contract development and …See details»
Avid Bioservices Completes Construction of New, World-Class Cell …
TUSTIN, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Avid Bioservices, Inc. Company Profile | Tustin, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Avid Bioservices, Inc. of Tustin, CA. Get the latest business insights from Dun & Bradstreet.See details»
Avid Bioservices Launches New Company Website Designed to
Feb 10, 2025 The new site, which can be visited at www.avidbio.com, combines Avid’s elevated brand story and visual identity with improved functionality and navigation, all aimed at …See details»
Avid Bioservices Completes Construction of New, World-Class Cell …
About Avid Bioservices, Inc. Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) …See details»
Avid Bioservices, Inc. - MassBio
Nov 4, 2021 Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The …See details»
Avid Bioservices - Crunchbase Company Profile & Funding
Feb 11, 2015 Avid Bioservices' expansion will double existing capacity to service both a $40m backlog and its owner Peregrine.See details»
Org Chart Avid Bioservices - The Official Board
The org chart of Avid Bioservices contains its 18 main executives including Nicholas Green, Daniel Hart and Richard Richieri.See details»
Avid Stockholders Approve Transaction with GHO and Ampersand
TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing …See details»
Avid Bioservices to be Acquired by GHO Capital Partners and …
News November 6, 2024 Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction Tustin, CA & London, UK & Boston, …See details»
Avid Bioservices Launches New Company Website Designed to
TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working …See details»
Avid Bioservices Completes Construction of New, World-Class
Oct 17, 2023 --Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality …See details»
Avid Bioservices Launches New Company Website Designed to
Feb 10, 2025 --Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality …See details»
Avid Bioservices Earns Committed Badge from EcoVadis for …
TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) …See details»
The Power of “What if” – Avid Bioservices
By Nicholas Green, President & CEO We completely transformed the CDMO experience — and the effect is life-changing. Avid Bioservices’ founders have been inspired by the spirit of …See details»